Currently, about 5000 journal titles are indexed in MEDLINE. The Director of the NLM decides whether or not to index a journal, on the basis of considerations of both scientific quality and policy. Specifically, the NLM's Literature Selection Technical Review Committee (LSTRC) reviews and assesses the quality of journals, while NLM's Board of Regents determines the mix of types of journals to be indexed, according to considerations of program relevance. 1 In fact, our Journal was indexed in MEDLINE over the period 1975 to 1997. While the specific reasons for halting our indexing are unknown, the NLM has been known to drop currently indexed journals to accommodate new ones.
In 2004, the CJHP submitted an application for indexing that was unsuccessful. Although we would have been allowed to reapply after a minimum of 3 years, the Editorial Board believed it best to hold off until we were more confident of success. As such, we have been "beefing up" the Journal, 2 while carefully examining the NLM's criteria for indexing and scrutinizing what it took for other journals to achieve indexing status.
I would like to take this opportunity to describe some of the additional changes we are planning for the CJHP and to explain why we are advocating these changes and why we believe we can be successful in our effort to achieve indexing status.
In planning for our next application for indexing (in early 2015), we have adopted the following primary goals: (1) to improve the CJHP's scope and coverage, making the Journal more internationally relevant; (2) to continue improving the quality of the CJHP's review articles, clinical research papers, case reports, and editorials; (3) to further improve the LSTRC's perception of the strength and credibility of the CJHP's Editorial Board and the Journal's editorial independence; (4) to improve the CJHP's perceived importance to critical audiences, specifically clinical pharmacists, educators and preceptors, hospital pharmacy administrators, and researchers; (5) to ensure that the CJHP's content meets the LSTRC criteria for indexing; and (6) to heed the NLM's caveat that "publications that consist primarily of reprinted articles, reports of association activities, abstracts of the literature, news items or book reviews, will not usually be indexed". 1 Specifically, we plan the following changes, among others. We will have at least one individual from outside North America on our Editorial Board at all times. We will regularly solicit guest editorials from prominent pharmacists (including recipients of the CSHP Distinguished Service Award and individuals based outside of Canada). Starting with the current issue, we have updated our column categories as follows: Editorial, Original Research, Reviews, Clinical Practice, Pharmacy Education, Social and Administrative Pharmacy, Case Reports, Books and Other Media, Letters, and the ever-popular Point Counterpoint; the Practice Spotlight column has now been eliminated, effective with this issue. We have started formally soliciting systematic reviews from experts across Canada and, in conjunction with the CSHP Research Committee, will be identifying topics and prospective authors for a Research Primer series. These are just a few of the changes that our readers will see over the coming months.
For now, we will continue publishing reports from the CSHP Presidential Team and Executive Director, as well as abstracts from the Society's Professional Practice Conference and Summer Educational Session. We are in discussions with the CSHP Executive Committee and Council about the best way to reduce the "less scientific" content (i.e., Society news-like items) to follow suit with other successfully indexed journals.
Only 20% to 25% of journal titles reviewed by the NLM are selected for indexing. 3 However, if we do what it takes, the CJHP will reach this goal!
